Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
RLAY
#1753
Relay Therapeutics, Inc. Common Stock
10.2
6
+14.77%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+14.77%
Variazione Mensile
+21.42%
Variazione di 6 mesi
+185.79%
Variazione Annuale
+213.76%
Chiusura Precedente
8.9
4
Open
10.2
6
Bid
Ask
Low
10.2
6
High
10.2
6
Volume
219
Mercati
Mercato Azionario Statunitense
Salute
RLAY
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
90.4 M
108.28 M
121.38 M
131.18 M
169.52 M
178.73 M
—
Valuation ratios
Enterprise value
3.85 B
3.05 B
1.67 B
1.41 B
574.14 M
1.43 B
3.08 B
Price to earnings ratio
—
—
-5.81
-4.25
-1.75
-5.25
-11.28
Price to sales ratio
—
—
1 222.3
56.88
58.82
—
—
Price to cash flow ratio
—
—
7.36
4.84
2.36
6.17
13.04
Price to book ratio
—
—
1.78
1.93
0.76
2.56
3.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.07
0.36
0.26
0.41
0.39
0.44
0.39
Return on equity %
0.07
0.41
0.31
0.45
0.43
0.49
0.43
Return on invested capital %
65.63
278.88
147.72
187.57
214.71
197.28
—
Gross margin %
100
100
100
100
100
100
—
Operating margin %
67.51
1 204.02
21.67 K
1 460.11
3 722.07
1 971.59
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
63.41
1 201.29
21.04 K
1 338.66
3 374.72
1 800.58
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
56.49
40.14
16
25.44
15.95
22.61
82.63
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.1
0.03
0
0.03
0.01
0.02
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
2.04
2.45
1.74
1.37
1.38
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.35
1.17
0.87
0.49
2.24
Net current asset value per share
—
—
9.08
6.28
5.66
3.37
15.33
Tangible book value per share
—
—
8.45
6.12
5.43
3.3
14.96
Working capital per share
—
—
8.52
6.04
5.31
3.22
14.59
Book value per share
—
—
8.47
6.13
5.44
3.3
14.98
Notizie
Relay Therapeutics stock hits 52-week high at 9.64 USD
Gli EPS di Relay hanno battuto le aspettative per 0,09$, il fatturato supera le previsioni
Relay earnings beat by $0.09, revenue topped estimates
Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates
Utili Relay Therapeutics sotto i riflettori dopo svolta FDA
Relay Therapeutics earnings in spotlight after FDA breakthrough
BB Biotech FY 2025: utili +660%, outlook 2026 cauto
Relay earnings in focus as FDA breakthrough fuels optimism
Le azioni di Relay Therapeutics salgono dopo lo status di Breakthrough Therapy della FDA
Relay Therapeutics stock rises after FDA grants Breakthrough Therapy status
FDA concede lo status di terapia innovativa al farmaco di Relay per il cancro al seno
FDA grants breakthrough therapy status to Relay’s breast cancer drug